Aura Biosciences
AURA
104 hedge funds and large institutions have $317M invested in Aura Biosciences in 2025 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 32 increasing their positions, 29 reducing their positions, and 15 closing their positions.
73% more first-time investments, than exits
New positions opened: 26 | Existing positions closed: 15
37% more capital invested
Capital invested by funds: $232M → $317M (+$85.3M)
21.35% more ownership
Funds ownership: 79.35% → 100.69% (+21%)
11% more funds holding
Funds holding: 94 → 104 (+10)
10% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 29
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$29.8M |
| 2 |
SCM
Suvretta Capital Management
New York
|
+$9.6M |
| 3 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$7.6M |
| 4 |
SB
Samsara BioCapital
Palo Alto,
California
|
+$5.85M |
| 5 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$4.97M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$2.56M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$885K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$884K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$559K |
| 5 |
RCM
Regency Capital Management
Honolulu,
Hawaii
|
-$489K |
AURA Hedge Fund Activity: Q2 2025 in Review
104 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q2 2025, worth a combined $317M — up 37% from $232M a quarter earlier.
Buyers outnumbered sellers: 26 funds opened new AURA positions and 15 closed out — a net gain of 11 holders — while 32 added to existing stakes and 29 trimmed.
The largest buyer was Frazier Life Sciences Management, opening a new position worth an estimated $29.8M. The largest seller was BlackRock, cutting an estimated $2.56M.
- 104 institutional investors held Aura Biosciences (AURA) as of Q2 2025, up from 94 in Q1 2025.
- Funds reported $317M of Aura Biosciences stock for Q2 2025, up 37% quarter-over-quarter.
- 26 funds opened new Aura Biosciences positions in Q2 2025 and 15 closed out, a net change of +11 holders.
- The largest Aura Biosciences buyer in Q2 2025 was Frazier Life Sciences Management, an estimated $29.8M added.
- The largest Aura Biosciences seller in Q2 2025 was BlackRock, an estimated $2.56M sold.
Based on aggregated 13F filings for Q2 2025.